Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionSG Americas Securities, LLC
Latest Disclosed Ownership59,267 shares
Latest Disclosed Value $ 7,808
SG Americas Securities, LLC ownership in NBIX / Neurocrine Biosciences, Inc.

On April 16, 2026 - SG Americas Securities, LLC filed a 13F-HR form disclosing ownership of 59,267 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $7,808 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 9, 2026 disclosing 134,530 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of -55.95% during the quarter.

SG Americas Securities, LLC has a history of taking positions in derivatives of the underlying security (NBIX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:NBIX / Neurocrine Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-16 2026-03-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 59,267 -75,263 -55.95 8 -63.16 0.0084
2026-01-09 2025-12-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 134,530 119,339 785.59 19 850.00 0.0244
2025-10-23 2025-09-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 15,191 10,357 214.25 2 0.0072
2025-08-08 2025-06-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 4,834 -170,779 -97.25 1 -100.00 0.0025
2025-04-15 2025-03-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 175,613 174,551 16,436.06 19 0.0637
2025-01-17 2024-12-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 1,062 -7,022 -86.86 0 0.0006
2024-10-03 2024-09-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 8,084 -34,394 -80.97 1 -100.00 0.0034
2024-07-12 2024-06-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 42,478 42,478 6 0.0341
2024-05-06 2024-03-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 0 -7,180 -100.00 0 0.0000
2024-01-12 2023-12-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 7,180 -17,273 -70.64 1 -100.00 0.0088
2023-10-13 2023-09-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 24,453 24,453 3 0.0315
2023-07-10 2023-06-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 0 -30,030 -100.00 0 -100.00
2023-04-28 2023-03-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 30,030 22,676 308.35 3 0.0353
2023-02-02 2022-12-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 7,354 7,354 1 0.0107
2022-10-31 2022-09-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 0 -20,700 -100.00 0 -100.00
2022-07-29 2022-06-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 20,700 -22,553 -52.14 2,018 -50.23 0.0215
2022-04-29 2022-03-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 43,253 -76 -0.18 4,055 9.89 0.0297
2022-02-07 2021-12-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 43,329 5,131 13.43 3,690 0.71 0.0201
2021-11-01 2021-09-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 38,198 3,223 9.22 3,664 7.64 0.0172
2021-08-12 2021-06-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 34,975 -19,636 -35.96 3,404 -35.91 0.0158
2021-05-13 2021-03-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 54,611 48,039 730.96 5,311 743.02 0.0278
2021-02-04 2020-12-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 6,572 -9,356 -58.74 630 -58.88 0.0034
2020-11-09 2020-09-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 15,928 4,576 40.31 1,532 10.61 0.0097
2020-07-20 2020-06-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 11,352 -6,814 -37.51 1,385 -11.90 0.0115
2020-04-30 2020-03-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 18,166 16,821 1,250.63 1,572 984.14 0.0147
2020-01-28 2019-12-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 1,345 -2,234 -62.42 145 -55.11 0.0013
2019-11-04 2019-09-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 3,579 -1,413 -28.31 323 -23.28 0.0026
2019-07-29 2019-06-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 4,992 2,886 137.04 421 126.34 0.0029
2019-04-29 2019-03-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 2,106 135 6.85 186 31.91 0.0017
2019-01-31 2018-12-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 1,971 157 8.65 141 -36.77 0.0012
2018-11-06 2018-09-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 1,814 -27,426 -93.80 223 -92.24 0.0017
2018-08-07 2018-06-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 29,240 27,904 2,088.62 2,873 2,488.29 0.0259
2018-05-03 2018-03-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 1,336 -3,092 -69.83 111 -67.73 0.0009
2018-01-24 2017-12-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 4,428 4,428 344 0.0032
2017-11-07 2017-09-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 0 -2,326 -100.00 0 -100.00
2017-08-03 2017-06-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 2,326 -36,446 -94.00 107 -93.63 0.0010
2017-05-10 2017-03-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 38,772 -20,897 -35.02 1,679 -27.28 0.0148
2017-02-08 2016-12-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 59,669 56,428 1,741.07 2,309 1,307.93 0.0194
2017-02-08 2016-09-30 13F/A-1 NEUROCRINE BIOSCIENCES INC COM COM 64125C109 3,241 3,241 164 0.0017
2016-11-08 2016-09-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 3,241 164
2016-08-03 2016-06-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 0 -7,091 -100.00 0 -100.00
2016-05-12 2016-03-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 7,091 7,091 0.00 280 0.0020
2016-02-12 2015-12-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 0 -16,353 -100.00 0 -100.00
2015-11-09 2015-09-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 16,353 12,202 293.95 651 228.79 0.0039
2015-08-06 2015-06-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 4,151 -10,072 -70.81 198 -64.96 0.0013
2015-05-13 2015-03-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 14,223 -1,510 -9.60 565 60.97 0.0034
2015-02-12 2014-12-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 15,733 15,733 18.20 351 132.45 0.0017
2014-02-12 2013-12-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 0 -13,310 -100.00 0 -100.00
2013-11-12 2013-09-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 13,310 4,508 51.22 151 27.97 0.0006
2013-08-13 2013-06-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 8,802 8,802 118 0.0006
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-04-28 2023-03-31 13F NEUROCRINE BIOSCIENCES OPT Call 0 -100.00 0 n/a n/a n/a
2023-02-02 2022-12-31 13F NEUROCRINE BIOSCIENCES OPT Call 20,000 0 n/a n/a n/a
2020-07-20 2020-06-30 13F NEUROCRINE BIOSCIENCES OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-04-30 2020-03-31 13F NEUROCRINE BIOSCIENCES OPT Call 79,000 276 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-11-09 2020-09-30 13F NEUROCRINE BIOSCIENCES OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-07-20 2020-06-30 13F NEUROCRINE BIOSCIENCES OPT Put 55,000 17.27 187 -43.84 n/a n/a n/a
2020-04-30 2020-03-31 13F NEUROCRINE BIOSCIENCES OPT Put 46,900 333 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.